Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-10-23-Speech-2-524-062"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-10-23"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"en"^^xsd:language2
lpv:document identification number	"en.20121023.45.2-524-062"2
lpv:hasSubsequent	lp_eu:2012-10-23-Speech-2-524-0932
lpv:speaker	lp:Marian Harkin2
lpv:spoken text	"I am pleased that MEPs have approved EGF funding for AstraZeneca Sweden. There were 987 redundancies following the closures of the company’s research and development sites in the municipalities of Lund and Umeå, and limiting operations in Mölndal and Södertälje. 700 of these workers – those who are expected to have the greatest difficulty gaining new employment – will be targeted for support from the EGF. The package aims to help the workers by offering them occupational guidance and job-search assistance, as well as vocational training and retraining, and aid for self-employment. The pharmaceutical industry worldwide is increasingly reorganising and consolidating in order to retain its competitiveness, so I am satisfied that the EGF is yet again demonstrating clearly the EU’s added value in providing a safety net for those who lose out as a result of these changes."@en1
lpv:spokenAs	substitute; AGRI (2012-01-19--2014-06-30)3,3 substitute; PETI (2012-01-19--2014-06-30)3,3 member; Delegation for relations with the United States (2009-09-16--2014-06-30)3,3 unknown; - (2009-07-14--2014-06-30)3,3 substitute; Delegation for relations with Australia and New Zealand (2009-09-16--2014-06-30)3,3 member; EMPL (2012-01-19--2014-06-30)3,3 member_of_the_bureau; ALDE (2009-07-20--2014-06-30)3,3
lpv:unclassifiedMetadata	"Marian Harkin (ALDE ),"1 "in writing."1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph